
Chinese sub discovers deepest-ever creatures 10 km undersea
PARIS (AFP)A Chinese submersible has discovered thousands of worms and molluscs nearly 10 kilometres (six miles) below sea level in the Mariana Trench, the deepest colony of creatures ever observed, a study revealed on Wednesday.The discovery in Earth's deepest underwater valley suggests that there could be much more life thriving in the hostile conditions at the bottom of our planet's largely unexplored oceans than previously thought, the China-led team of scientists said.Almost all life on Earth is supported by light from the Sun. However in the total darkness at the bottom of the world, these creatures live off of chemicals such as methane seeping through cracks in the seafloor, a process called chemosynthesis.Last year, the Chinese submersible "Fendouzhe" -- or "Striver" -- dove 23 times into the depths of the Mariana Trench in the western Pacific Ocean with researchers on board, according to the study in the journal Nature.They found colonies of thousands of marine tubeworms and molluscs called bivalves at depths ranging from 2,500 to 9,533 metres (8,200 to 31,000 feet) deep.Video released alongside the study showed fields of tubeworms, which grew up to 30 centimetres (12 inches) long, as well as piles of molluscs and clams.Spiky crustaceans, free-floating marine worms, sea cucumbers, feathery-armed sea lilies and other invertebrates were also recorded in the depths.The study marked "the discovery of the deepest and the most extensive chemosynthesis-based communities known to exist on Earth," its authors said.Given that other ocean trenches are similar, "such chemosynthesis-based communities might be more widespread than previously anticipated," they added.The researchers said they also found "compelling evidence" that methane was being produced by microbes, with the tubeworms tending to cluster around microbial mats that resemble snow.Previous studies have found thriving communities of single-cell organisms on the ocean floor, but few large animals.But a remotely operated vehicle discovered tubeworms and other marine invertebrates living in hydrothermal vents in the crust below the seafloor two kilometres deep in the Pacific, research said last year.The new study was published as nations wrangle over the contentious issue of deep-sea mining. China, the United States and others have expressed interest in mining the depths for valuable minerals.Ocean scientists warn that mining the little-explored seafloor, one of the last wild zones on the planet, could decimate fragile ecosystems that are not yet well understood.Despite recent talks, the International Seabed Authority -- which oversees deep-sea mining in international waters -- has yet to adopt long-awaited rules governing the industry.Chinese media has previously reported that the Fendouzhe submersible mission will conduct research on "deep-sea materials".Only a handful of people have ever visited the bottom of the Mariana Trench, which is a crescent-shaped depression in the Earth's crust that is deeper than Mount Everest is high.The first explorers visited the trench in 1960 on a brief expedition.But after that, there were no missions until Hollywood director James Cameron made the first solo trip to the bottom in 2012, describing a "desolate" and "alien" environment.
The water pressure at the bottom of the trench is a crushing eight tons per square inch, more than a thousand times the atmospheric pressure at sea level.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gulf Business
an hour ago
- Gulf Business
Science journal spotlights AUS study on sustainable soil systems
Image: Supplied While dry, degraded soil may appear lifeless on the surface, beneath it lies a complex and dynamic system of interaction between plant roots and microbial communities. These biological exchanges, though often invisible, play a critical role in determining soil health and crop productivity. Now, new research published in Science —one of the world's leading scientific journals—by American University of Sharjah (AUS) and international collaborators, is challenging conventional approaches to agriculture and highlighting the need to manage these relationships with ecological precision. The paper, titled 'Steering Plant–Soil Feedback for Sustainable Agriculture,' is the result of a year-long collaboration between five scientists: Dr. John Klironomos, Professor of Biology, Chemistry and Environmental Sciences and Associate Dean for Research and Innovation at the AUS College of Arts and Sciences; Professors Guangzhou Wang, Fusuo Zhang and Junling Zhang from China Agricultural University; and Professor Wim van der Putten from the Netherlands Institute of Ecology and Wageningen University. At the heart of the research is the concept of plant–soil feedback—the idea that plants shape the microbial environment in the soil via their root systems and biochemical signals. These microbial communities, in turn, influence how plants access nutrients, water, and protection from pathogens. The paper emphasizes that depending on how these feedback loops are managed, they can either support or undermine the sustainability of agricultural systems. Arid regions For the UAE and other arid regions grappling with saline soils, limited organic matter and water scarcity, this research offers practical pathways forward. At AUS, Dr. Klironomos and his team are conducting field trials using microbial inoculants—beneficial fungi and bacteria introduced into the soil—and biostimulants to support the growth of desert crops like wheat and date palms. These trials are designed to test how microbial partners can enhance resilience under harsh conditions. 'Plants and microbes have always influenced each other,' said Dr. Klironomos. 'The key is managing those interactions with purpose, especially in environments where every biological advantage matters. This work helps shift the focus from short-term yield to long-term soil function.' The study also repositions several traditional agricultural practices—such as crop rotation, intercropping, and reduced tillage—as valuable ecological tools. When applied with knowledge of microbial dynamics, these practices can improve soil health, reduce reliance on chemical inputs, and contribute to more stable growing environments over time. 'Microbial life is one of agriculture's most overlooked tools,' said co-author Professor Junling Zhang. 'When we support the living processes in soil, we create systems that are more sustainable, more adaptive and better aligned with how ecosystems naturally function.' Read: In addition to ecological insights, the paper also draws from advances in molecular biology. Researchers are now identifying the genetic and molecular signals that facilitate plant–microbe communication, opening up new breeding strategies to develop crop varieties that naturally enhance soil microbial interactions. Building on this foundation, AUS has joined hands with regional experts to form the Sharjah Sustainable Agriculture Research Group. The team includes Dr. Klironomos; Dr. Mohamed Abouleish, Professor in Biology, Chemistry and Environmental Sciences; Dr. Tarig Ali, Professor in Civil Engineering; and Dr. Ali El-Keblawy from the University of Sharjah. Together, they are combining expertise in soil ecology, native plant conservation, biotechnology, and spatial analysis to restore the biological function of arid soils. At the core of the research is a shift in perception: soil is not inert—it is a living ecosystem. It changes, it breathes, and it responds to how we care for it. The authors argue that viewing soil through this lens can pave the way for agricultural solutions that simultaneously address food security, climate adaptation, and biodiversity conservation. The full paper appears in the July 2025 edition of Science . You can read it


Arabian Post
a day ago
- Arabian Post
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR – Media OutReach Newswire – 1 August 2025 –Cushman & Wakefield, a leading global real estate services firm, today released itsreport. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. ADVERTISEMENT Recent national policy initiatives on the Chinese mainland Types of policies Detail information Opening to Foreign Investment In 2024, China eased restrictions on foreign investments in stem cell research, gene therapy, and genetic diagnostics within Free Trade Zones (FTZs) like Beijing, Shanghai, Guangdong, and Hainan. Regulatory Incentives The State Council's Circular No. 53 introduced measures such as regulatory data protection and marketing exclusivity for select pharmaceutical products, including orphan and paediatric drugs. Wholly Foreign-Owned Hospitals China now permits the establishment of wholly foreign-owned hospitals in cities like Beijing, Shanghai, and Shenzhen, enhancing healthcare services and encouraging foreign investment. Source: Cushman & Wakefield Research Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs ADVERTISEMENT Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The 'R&D + Manufacturing + Service' ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.' Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'. Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'. Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'. Please click here to download the full report. Hashtag: #Cushman&Wakefield The issuer is solely responsible for the content of this announcement. About Cushman & Wakefield Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In Greater China, a network of 23 offices serves local markets across the region. In 2024, the firm reported revenue of $9.4 billion across its core services of Valuation, Consulting, Project & Development Services, Capital Markets, Project & Occupier Services, Industrial & Logistics, Retail, and others. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit or follow us on LinkedIn (


Zawya
a day ago
- Zawya
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR - Media OutReach Newswire - 1 August 2025 - Cushman & Wakefield, a leading global real estate services firm, today released its Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland report. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. Recent national policy initiatives on the Chinese mainland Types of policies Detail information Opening to Foreign Investment In 2024, China eased restrictions on foreign investments in stem cell research, gene therapy, and genetic diagnostics within Free Trade Zones (FTZs) like Beijing, Shanghai, Guangdong, and Hainan. Regulatory Incentives The State Council's Circular No. 53 introduced measures such as regulatory data protection and marketing exclusivity for select pharmaceutical products, including orphan and paediatric drugs. Wholly Foreign-Owned Hospitals China now permits the establishment of wholly foreign-owned hospitals in cities like Beijing, Shanghai, and Shenzhen, enhancing healthcare services and encouraging foreign investment. Source: Cushman & Wakefield Research Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The " R&D + Manufacturing + Service" ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, "Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value." Johnathan Wei, President, Project & Occupier Services, China, said, "Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation". Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said," Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals". Shaun Brodie, Head of Research Content, Greater China, "Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value". Please click here to download the full report. Hashtag: #Cushman&Wakefield The issuer is solely responsible for the content of this announcement. About Cushman & Wakefield Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In Greater China, a network of 23 offices serves local markets across the region. In 2024, the firm reported revenue of $9.4 billion across its core services of Valuation, Consulting, Project & Development Services, Capital Markets, Project & Occupier Services, Industrial & Logistics, Retail, and others. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit or follow us on LinkedIn ( Cushman & Wakefield